[Second malignant neoplasm after therapy of Hodgkin's disease (author's transl)].
D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects; D002968:Clavicle; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy*; D006801:Humans; D012516:Osteosarcoma / Q000150:complications*; D011867:Radioisotope Teletherapy / Q000009:adverse effects; D013997:Time Factors
D000970:Antineoplastic Agents; D003037:Cobalt Radioisotopes
Zweittumor nach M. Hodgkin-Therapie.